Shelley J Orwick (Shelley Orwick)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 16

Top Venues

Blood advances

Cancers

Leukemia

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Christopher C Oakes, Jonathan E Kolitz, Geoffrey L Uy, Wendy Stock, Bayard L Powell, Deedra Nicolet, Erin K Hertlein, Krzysztof Mrózek, James S Blachly, Ann-Kathrin Eisfeld, Sharyn D Baker, John C Byrd
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia (Alliance). Blood advances (2023)
Melanie Rebechi, Jessica Kohlschmidt, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, James S Blachly, Shelley J Orwick, Karilyn T M Larkin, Christopher C Oakes, Andrew Hantel, Andrew J Carroll, William Blum, Bayard L Powell, Geoffrey L Uy, Richard M Stone, Richard A Larson, John C Byrd, Electra D Paskett, Jesse J Plascak, Ann-Kathrin Eisfeld
Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances (2023)
Krzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, Deedra Nicolet, Andrew J Carroll, Kellie J Archer, Alice S Mims, Karilyn T Larkin, Shelley J Orwick, Christopher C Oakes, Jonathan E Kolitz, Bayard L Powell, William G Blum, Guido Marcucci, Maria R Baer, Geoffrey L Uy, Wendy Stock, John C Byrd, Ann-Kathrin Eisfeld
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia (2023)
Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J Orwick, Daelynn R Buelow, Sydney Fobare, Christopher C Oakes, Jonathan E Kolitz, Geoffrey L Uy, Wendy Stock, Bayard L Powell, Deedra Nicolet, Erin K Hertlein, Krzysztof Mrózek, James S Blachly, Ann-Kathrin Eisfeld, Sharyn D Baker, John C Byrd
Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood advances 7 (16) (2023)
Michael Ozga, Deedra Nicolet, Krzysztof Mrózek, Ayse S Yilmaz, Jessica Kohlschmidt, Karilyn T Larkin, James S Blachly, Christopher C Oakes, Jill Buss, Christopher J Walker, Shelley J Orwick, Vindi Jurinovic, Maja Rothenberg-Thurley, Annika Dufour, Stephanie Schneider, Maria Cristina Sauerland, Dennis Görlich, Utz Krug, Wolfgang E Berdel, Bernhard J Woermann, Wolfgang Hiddemann, Jan Braess, Marion Subklewe, Karsten Spiekermann, Andrew J Carroll, William G Blum, Bayard L Powell, Jonathan E Kolitz, Joseph O Moore, Robert J Mayer, Richard A Larson, Geoffrey L Uy, Wendy Stock, Klaus H Metzeler, H Leighton Grimes, John C Byrd, Nathan Salomonis, Tobias Herold, Alice S Mims, Ann-Kathrin Eisfeld
Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). Leukemia (2023)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Karilyn T M Larkin, Deedra Nicolet, Benjamin J Kelly, Krzysztof Mrózek, Stephanie LaHaye, Katherine E Miller, Saranga Wijeratne, Gregory L Wheeler, Jessica Kohlschmidt, James S Blachly, Alice S Mims, Christopher J Walker, Christopher C Oakes, Shelley J Orwick, Isaiah Boateng, Jill Buss, Adrienne Heyrosa, Helee Desai, Andrew J Carroll, William Blum, Bayard L Powell, Jonathan E Kolitz, Joseph O Moore, Robert J Mayer, Richard A Larson, Richard M Stone, Electra D Paskett, John C Byrd, Elaine R Mardis, Ann-Kathrin Eisfeld
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML. Blood advances 6 (19) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Steven Sher, Ethan C Whipp, Janek Walker, Pu Zhang, Larry Beaver, Katie Williams, Shelley J Orwick, Janani Ravikrishnan, Brandi Walker, Elizabeth Perry, Charles T Gregory, Matthew Purcell, Alexander Pan, Pearlly S Yan, Lapo Alinari, Amy J Johnson, Melanie M Frigault, Joy M Greer, Ahmed Hamdy, Raquel Izumi, Xiaokui M Mo, Deepa Sampath, Jennifer A Woyach, James S Blachly, John C Byrd, Rosa Lapalombella
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. Leukemia (2022)
Daelynn R Buelow, Bhavana Bhatnagar, Shelley J Orwick, Jae Yoon Jeon, Eric D Eisenmann, Jack C Stromatt, Navjot Singh Pabla, James S Blachly, Sharyn D Baker, Bradley W Blaser
BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors. Blood advances 6 (17) (2022)
Eric D Eisenmann, Jack C Stromatt, Sydney Fobare, Kevin M Huang, Daelynn R Buelow, Shelley J Orwick, Jae Yoon Jeon, Robert H Weber, Bill Larsen, Alice S Mims, Erin Hertlein, John C Byrd, Sharyn D Baker
TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers 15 (1) (2022)
Pu Zhang, Lindsey T Brinton, Katie Williams, Steven Sher, Shelley J Orwick, Lai Tzung-Huei, Alice S Mims, Christopher C Coss, Samuel K Kulp, Youssef Youssef, Wing Keung Chan, Shaneice R Mitchell, Allison Mustonen, Matthew Cannon, Hannah Phillips, Amy M Lehman, Tierney Kauffman, Larry Beaver, Daniel Canfield, Nicole R Grieselhuber, Lapo Alinari, Deepa Sampath, Pearlly Yan, John C Byrd, James S Blachly, Rosa Lapalombella
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (8) (2021)
Sydney Fobare, Jessica Kohlschmidt, Hatice Gulcin Ozer, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, Ramiro Garzon, James S Blachly, Shelley J Orwick, Andrew J Carroll, Richard M Stone, Eunice S Wang, Jonathan E Kolitz, Bayard L Powell, Christopher C Oakes, Ann-Kathrin Eisfeld, Erin K Hertlein, John C Byrd
Molecular associations, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia (Alliance). Blood advances (2021)
Bhavana Bhatnagar, Jessica Kohlschmidt, Krzysztof Mrózek, Qiuhong Zhao, James L Fisher, Deedra Nicolet, Christopher J Walker, Alice S Mims, Christopher Oakes, Brian Giacopelli, Shelley J Orwick, Isaiah Boateng, James S Blachly, Sophia E Maharry, Andrew J Carroll, Bayard L Powell, Jonathan E Kolitz, Richard M Stone, John C Byrd, Electra D Paskett, Albert de la Chapelle, Ramiro Garzon, Ann-Kathrin Eisfeld
Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia. Cancer discovery 11 (3) (2020)
Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, Christopher J Walker, Deedra Nicolet, Dimitrios Papaioannou, James S Blachly, Shelley J Orwick, Andrew J Carroll, Jonathan E Kolitz, Bayard L Powell, Richard M Stone, Albert de la Chapelle, John C Byrd, Clara D Bloomfield
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A. Proceedings of the National Academy of Sciences of the United States of America 117 (42) (2020)

Shelley J Orwick.css-eqlu8i{font-size:small;padding-left:4px;} (Shelley Orwick)

Publication Activity (10 Years)

Top Topics

Top Venues

Shelley J Orwick (Shelley Orwick)